01 Dr. Reddy's Laboratories (4)
02 NanoAlvand (1)
03 Polfa Tarchomin (1)
04 Accord healthcare (3)
05 Accure Labs (1)
06 Alembic Pharmaceuticals Limited (1)
07 Amneal Pharmaceuticals (1)
08 Apotex Inc (1)
09 AstraZeneca (11)
10 Aurobindo Pharma Limited (2)
11 CHEMO (1)
12 Chia Tai Tianqing Pharmaceutical Group (1)
13 FORMATIVE PHARMA INC. (1)
14 Fresenius Kabi USA, LLC (1)
15 GetWell Pharmaceutical (1)
16 Glenmark Pharmaceuticals (1)
17 HBT Labs (1)
18 Hangzhou Jiuyuan Gene Engineering (1)
19 Hansoh Pharma (1)
20 Intas Pharmaceuticals (1)
21 InterPharma (1)
22 Sagent Pharmaceuticals (1)
23 Sakar Healthcare (1)
24 Sandoz B2B (6)
25 Teva Pharmaceutical Industries (3)
26 TherDose Pharma (1)
27 Viatris (2)
28 Xiromed (1)
29 Zydus Pharmaceuticals (1)
01 Fulvestrant 250Mg 5Ml 1 Units Parenteral Use (1)
02 Fulvestrant 250Mg 5Ml 2 Units Parenteral Use (1)
03 INJ (2)
04 INJECTION (1)
05 Injection (9)
06 Injection fluid, resolution (2)
07 Oily Solution (1)
08 PFS (3)
09 Pre Filled Syringes (1)
10 Prefilled Syringe (1)
11 SOLUTION (6)
12 SOLUTION FOR INJECTION, PRE-FILLED SYRINGE (2)
13 SOLUTION;INTRAMUSCULAR (19)
14 Solution for Injection (1)
15 Blank (3)
01 DISCN (2)
02 Dossier Availability: Q1 2027 (1)
03 Generic (4)
04 Lead Market Dossiers- Approved in both US & EU (1)
05 Lead Market Dossiers- Filed (1)
06 Originator (2)
07 Prescription (6)
08 RX (17)
09 Blank (19)
01 Eranfu 250 (1)
02 FASLODEX (3)
03 FASTELEV (1)
04 FULVESTRANT (17)
05 FULVESTRANT ACCORD (1)
06 FULVESTRANT EVER PHARMA (1)
07 FULVESTRANT INJECTION (4)
08 FULVETHER (1)
09 Faslodex (7)
10 Fularent (1)
11 Fulvestrant Mylan (1)
12 Fulvestrant Sandoz (2)
13 TEVA-FULVESTRANT INJECTION (1)
14 VESTRANT (1)
15 Blank (11)
01 Australia (3)
02 Canada (6)
03 China (1)
04 India (7)
05 Iran (1)
06 Italy (2)
07 Norway (2)
08 Poland (1)
09 South Africa (5)
10 Spain (1)
11 Sweden (2)
12 Switzerland (3)
13 USA (19)